IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity

in CHF 1 000

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2022

 

11 080

 

(9 205)

 

3 281 618

 

3 283 493

Dividend (CHF 3.85 per share)

 

 

 

(212 242)

 

(212 242)

Trade with treasury shares

 

 

(27 303)

 

 

(27 303)

Total comprehensive income for the period

 

 

 

(322 648)

 

(322 648)

Balances at September 30, 2022

 

11 080

 

(36 508)

 

2 746 727

 

2 721 299

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2023

 

11 080

 

(36 508)

 

2 711 563

 

2 686 135

Dividend (CHF 2.85 per share)

 

 

 

(156 311)

 

(156 311)

Total comprehensive income for the period

 

 

 

(315 723)

 

(315 723)

Balances at September 30, 2023

 

11 080

 

(36 508)

 

2 239 529

 

2 214 101

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer